Where does Medlumics S.L. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medlumics S.L. ranks #11,730 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medlumics S.L. hold?

Medlumics S.L. holds 26 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Medlumics S.L.'s Innovation Score?

Medlumics S.L. has an Innovation Score of 42.9 out of 100 (top 29% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medlumics S.L. focus on?

Medlumics S.L.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 19 patents, ranking #930 of 7,127 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Medlumics S.L.'s patent grant rate increasing or decreasing?

Medlumics S.L.'s recent grant velocity is -56% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Medlumics S.L.'s patents?

Medlumics S.L.'s patents average 20.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medlumics S.L. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medlumics S.L.

USPTO PatentsView assignee record - 26 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medlumics ranks #11,730 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 9 technology areas.

#11,730
of 49,997 US assignees by volume: Top 29%
by Innovation Score (42.9/100): 20.9
avg claims per patent: -56%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11730 · Foreign Corporation #11,730 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,730/49,997
PHOTO-FINISH Mad Apparel
CPC-NARROW A61B · 9 areas
INNOV-PAR 42.9/100
CLAIMS-DENSE 20.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -56% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mad Apparel, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medlumics’s 42.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (27%) Velocity 8.3 pts (19%) Breadth 10.6 pts (25%) Claim depth 12.6 pts (29%)

Qualcomm Incorporated · highest

85
Elite Material… · near

43
iTool Equipment… · near

43
Medlumics S L · this assignee

43
Nagase & · near

43
Reciprocal Labs · near

43
3D Lighting… · lowest

7

What this shows Medlumics's Innovation Score is 42.9/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medlumics?

Each dot is one of Medlumics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medlumics’s own 20.9 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medlumics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medlumics's grants concentrate

Medlumics S.L. is a focused PatentsView assignee: 9 CPC subclasses with 73.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2015. By volume, Medlumics sits between Mad Apparel, Inc. and Monrovia Nursery.

Medlumics's three-year grant acceleration

Medlumics S.L. shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mad Apparel

26
Martin Engineering

26
Mauser Werke

26
Max-delbrück-cent…

26
Metal Fusion

26
Mighty Oak Medical

26
Monolith Materials

26
Monrovia Nursery

26
Medlumics S L ◀

26

What this shows Medlumics holds 26 patents at rank #11,736, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medlumics

By rank, the assignees closest to #11,736 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medlumics's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medlumics, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Medlumics ranks #930 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Elite Electronic Material (KUNSHAN) Co., Ltd. 43 Reciprocal Labs Corporation 43 iTool Equipment Holding LLC 43 Nagase & Co., Ltd. 43

Medlumics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medlumics S.L. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.8%
2016	5	19.2%
2017	4	15.4%
2018	4	15.4%
2019	2	7.7%
2020	2	7.7%
2022	4	15.4%
2024	1	3.8%
2025partial year	3	11.5%

Which technologies does Medlumics S.L. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 19

G02B - Optical Elements, Systems OR Apparatus 15

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 12

G02F - Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optical Logic ELEMENTS; Optical ANALOGUE/DIGITAL Converters 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

B81C - Processes OR Apparatus Specially Adapted FOR THE Manufacture OR Treatment OF Microstructural Devices OR Systems 1

H01S - Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges Other Than Optical 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medlumics S.L.'s patent record in context - here's where to go next.

Medlumics S.L.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 73.1% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #11,730 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medlumics S.L. against Mad Apparel, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.